The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization

Jana Mehlich, Jörg Fischer, Christiane Hilger, Kyra Swiontek, Martine Morisset, Françoise Codreanu-Morel, Maximilian Schiener, Simon Blank, Markus Ollert, Ulf Darsow, Tilo Biedermann, Bernadette Eberlein*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

50 Citations (Scopus)

Abstract

Background: Galactose-alpha-1,3-galactose (alpha-gal) syndrome is characterized by the presence of serum specific IgE antibodies to alpha-gal and delayed type I allergic reactions to the carbohydrate alpha-gal after consumption of mammalian (red) meat products and drugs of mammalian origin. Diagnostics currently rely on patient history, skin tests, determination of serum specific IgE antibodies, and oral food or drug challenges. Objective: We sought to assess the utility of different basophil parameters (basophil reactivity and sensitivity, the ratio of the percentage of CD63+ basophils induced by the alpha-gal–containing allergen to the percentage of CD63+ basophils after stimulation with anti-FcεRI antibody [%CD63+/anti-FcεRI], and area under the dose-response curve [AUC]) as biomarkers for the clinical outcome of patients with alpha-gal syndrome compared with subjects with asymptomatic alpha-gal sensitization. Methods: In addition to routine diagnostics, a basophil activation test (Flow CAST) with different concentrations of alpha-gal–containing allergens (eg, commercially available alpha-gal–carrying proteins and pork kidney extracts) was performed in 21 patients with alpha-gal syndrome, 12 alpha-gal–sensitized subjects, and 18 control subjects. Results: Alpha-gal–containing allergens induced strong basophil activation in a dose-dependent manner in patients. Basophil reactivity at distinct allergen concentrations, the %CD63+/anti-FcεRI ratio across most allergen concentrations, the AUC of dose-response curves, and basophil allergen threshold sensitivity (CD-sens) with pork kidney extract were significantly higher in patients with alpha-gal syndrome compared with those in sensitized subjects. All parameters were negative in control subjects. Conclusion: The basophil activation test should be considered as an additional diagnostic test before performing time-consuming and potentially risky oral provocation tests. The %CD63+/anti-FcεRI ratio for all allergens and AUCs for pork kidney were the best parameters for distinguishing patients with alpha-gal syndrome from subjects with asymptomatic alpha-gal sensitization.

Original languageEnglish
Pages (from-to)182-189
Number of pages8
JournalJournal of Allergy and Clinical Immunology
Volume143
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Basophil activation test
  • CCR3
  • CD63
  • alpha-gal syndrome
  • asymptomatic alpha-gal sensitization
  • basophil allergen threshold sensitivity (CD-sens)
  • galactose-alpha-1,3-galactose
  • red meat allergy

Fingerprint

Dive into the research topics of 'The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization'. Together they form a unique fingerprint.

Cite this